A novel method to detect the Mexican founder mutation BRCA1 ex9-12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan(®) probes

In 2015, according to the National Institute of Statistics and Geography (INEGI), malignant breast tumors were the first cause of cancer fatality in women (6,273 fatalities) in Mexico, whereas 2,793 fatalities in women were due to ovarian cancer. A total of 5–10% of breast cancer and 10–15% of ovari...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Treviño, Denisse Aideé, León-Cachón, Rafael Baltazar Reyes, Villarreal-Garza, Cynthia, Méndez, Dione Aguilar Y, Aguilar-Martínez, Elisa, Barrera-Saldaña, Hugo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072190/
https://www.ncbi.nlm.nih.gov/pubmed/29901183
http://dx.doi.org/10.3892/mmr.2018.9141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072190/
https://www.ncbi.nlm.nih.gov/pubmed/29901183
http://dx.doi.org/10.3892/mmr.2018.9141

Ejemplares similares